Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
228 hedge funds and large institutions have $5.13B invested in Loxo Oncology, Inc in 2018 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 93 increasing their positions, 68 reducing their positions, and 24 closing their positions.
71% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 24
71% more call options, than puts
Call options by funds: $36.8M | Put options by funds: $21.6M
37% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 68
7% more funds holding
Funds holding: 213 → 228 (+15)
0% more capital invested
Capital invested by funds: $5.11B → $5.13B (+$19.3M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$48.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.3M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$43M |
| 4 |
Alkeon Capital Management
New York
|
+$33.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$235M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$65.6M |
| 3 |
O
OrbiMed
New York
|
-$35M |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$27.5M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$25.7M |
LOXO Hedge Fund Activity: Q3 2018 in Review
228 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2018, worth a combined $5.13B — up 0.38% from $5.11B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new LOXO positions and 24 closed out — a net gain of 17 holders — while 93 added to existing stakes and 68 trimmed.
The largest buyer was Eagle Asset Management, adding an estimated $48.9M. The largest seller was Aisling Capital, cutting an estimated $235M.
- 228 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2018, up from 213 in Q2 2018.
- Funds reported $5.13B of Loxo Oncology, Inc stock for Q3 2018, up 0.38% quarter-over-quarter.
- 41 funds opened new Loxo Oncology, Inc positions in Q3 2018 and 24 closed out, a net change of +17 holders.
- The largest Loxo Oncology, Inc buyer in Q3 2018 was Eagle Asset Management, an estimated $48.9M added.
- The largest Loxo Oncology, Inc seller in Q3 2018 was Aisling Capital, an estimated $235M sold.
Based on aggregated 13F filings for Q3 2018.